Back

Effect of extravascular renal denervation on 24-hour blood pressure patterns in resistant hypertension

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Hypertension treatment (1) Device Treatment and Intervention ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Hyukjin Park

Chonnam National University Medical School and Hwasun Hospital, Hwasun (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
Clinical feasibility and efficacy of renal denervation in hypertensive patients with aortic dissection
Doctor C. Lee (TW)
Abstract Slides Video
Presentation thumbnail
Breaking resistance: impact of renal denervation on blood pressure control and heart failure development
Doctor M. Lapsovs (Riga, LV)
Abstract Slides Video
Presentation thumbnail
Effects of GLP-1 RAs on blood pressure in young overweight/obese patients with new-onset hypertension: a multicenter, real-world prospective cohort study
Professor Y. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Policy gaps in access to single-pill antihypertensive combinations in Sub-Saharan Africa
Doctor A. Perkins (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension treatment (1)

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Early and sustained blood pressure control from discharge to 12 months after renal denervation: a time in therapeutic range analysis from a nationwide resistant hypertension registry
31 August 2025
thumbnail
Congress Presentation
Early reduction in central blood pressure and arterial stiffness after renal artery denervation in a patient with multiple renal arteries.
28 August 2026
thumbnail
Congress Presentation
Hot papers on device-based treatment of hypertension
1 September 2024
thumbnail
Congress Presentation
Renal denervation in hypertensive patients with renal impairment: ultra-long-term follow-up study
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources